Hello Community,

I'm reporting here because I can't get rid of a topic. It is now somehow not so dramatic, but since I like to have things neat (especially statistics ;)) I think about it again and again.

First of all: I have my account with ING. There I have at the time of the demerger/reverssplit of $GSK (old) held. These were then as expected by $HLN (-0,28 %) shares in the same amount and then the GSK shares were exchanged for new $GSK (-0,79 %) shares in a ratio of 5:4.

So far so good. But now GSK has taken the purchase value of the old GSK shares and simply split it 50/50. That means on the new GSK shares I have a nonsensically low purchase value (and am accordingly strongly in the plus) and with those of Haleon I have a nonsensically high purchase value, clearly over what was ever possible with the share.

Of course, it's great that if Haleon develops positively, I don't have to pay taxes on this increase in value when I sell it. However, if I sell GSK, I will be asked to pay a lot of money because it is almost 60% up. Does not feel right.

To make it perfect this did not happen analogously at Getquin.... But that could also be due to the fact that the ING to top it all off has also first settled Anders, then canceled and then divided as discussed...

Now the question, how were the acquisition values divided with you?